Enzymes and polymerases for the synthesis of RNA
View Patent ↗The invention relates to compositions and methods for the design, evolution, preparation, and/or manufacture of enzymes for use with polynucleotides, primary transcripts and mmRNA molecules.
1. A chimeric enzyme for synthesizing a capped RNA molecule, said chimeric enzyme comprising at least one capping enzyme and at least one nucleic acid polymerase, wherein said capped RNA molecule comprises at least one chemical modification, and wherein the at least one capping enzyme comprises a Vaccinia capping enzyme catalytic subunit (D1) and a Vaccinia capping enzyme stimulation subunit (D12), and where the at least one nucleic acid polymerase is T7 RNA polymerase (T7) in one of the following combinations:
a) a single polypeptide comprising D1 linked to D12 linked to T7;
b) a single polypeptide comprising D12 linked to D1 linked to T7;
c) a single polypeptide comprising T7 linked to D1 linked to D12; or
d) a single polypeptide comprising T7 linked to D12 linked to D1.
2. The chimeric enzyme of claim 1 , wherein the D1 subunit is encoded by the nucleic acid sequence SEQ ID NO: 178 and the D12 subunit is encoded by the nucleic acid sequence SEQ ID NO: 180.
3. The chimeric enzyme of claim 1 , wherein the at least one capping enzyme comprises a first region of linked nucleotides encoding the D1 subunit having the amino acid sequence SEQ ID NO: 179 and a second region of linked nucleotides encoding the D12 subunit having the amino acid sequence SEQ ID NO: 181.
4. The chimeric enzyme of claim 1 , wherein the at least one nucleic acid polymerase can utilize at least one chemical modification into the RNA during in vitro transcription.
5. The chimeric enzyme of claim 1 , wherein the T7 RNA polymerase is encoded by the nucleic acid sequence SEQ ID NO: 176.
6. The chimeric enzyme of claim 1 , wherein the T7 RNA polymerase comprises the amino acid sequence SEQ ID NO: 177.
7. The chimeric enzyme of claim 1 , wherein the at least one nucleic acid polymerase is a RNA polymerase variant and wherein the RNA polymerase variant is a T7 RNA polymerase variant.
8. The chimeric enzyme of claim 7 , wherein the T7 RNA polymerase variant is produced using continuous evolution.
9. The chimeric enzyme of claim 8 , wherein the continuous evolution is phage-assisted continuous evolution (PACE).
10. The chimeric enzyme of claim 7 , wherein the T7 RNA polymerase variant is capable of incorporating at least one chemical modification into RNA during in vitro transcription.
11. The chimeric enzyme of claim 7 , wherein the T7 RNA polymerase variant is characterized as having an increased transcription efficiency through GC-rich regions as compared to a wild type T7 RNA polymerase.
12. The chimeric enzyme of claim 7 , wherein the T7 RNA polymerase variant is characterized as having an increased transcription efficiency to produce messenger RNA as compared to a wild type T7 RNA polymerase.
13. The chimeric enzyme of claim 1 , wherein D1, D12 and/or T7 are linked using at least one linker peptide.
14. The chimeric enzyme of claim 13 , wherein the at least one linker peptide is selected from the group consisting of (GGGGS)n, LGGGGSGGGGSGGGGSAAA (SEQ ID NO: 173), LSGGGGSGGGGSGGGGSGGGGSAAA (SEQ ID NO: 174), and EGKSSGSGSESKST (SEQ ID NO: 175), wherein n refers to any whole integer.
15. The chimeric enzyme of claim 1 , further comprising an affinity purification tag, optionally a His tag.
16. The chimeric enzyme of claim 1 , wherein the capped RNA molecule is a messenger RNA.
17. A method of synthesizing a capped RNA molecule comprising at least one chemical modification, comprising contacting a DNA template with the chimeric enzyme of claim 1 under conditions sufficient for production of the capped RNA molecule.
18. The method of claim 17 , comprising a single-step reaction for both in vitro transcription and capping.
19. A kit comprising the chimeric enzyme of claim 1 and instructions for use thereof.